Literature DB >> 8684601

The interaction of dexamethasone with ondansetron on drug-induced emesis in the ferret.

J A Rudd1, K T Bunce, R J Naylor.   

Abstract

The potential of dexamethasone (0.5-20 mg/kg i.p.) to antagonize the emesis induced by cisplatin (10 mg/kg i.v.), apomorphine (0.25 mg/kg s.c.), morphine (0.5 mg/kg s.c.) and copper sulphate (100 mg/kg intragastric) was investigated alone and in combination with ondansetron in the ferret. There was a trend for dexamethasone 0.1-5 mg/kg to reduce cisplatin-induced emesis and for 0.05-2.5 mg/kg to delay the onset of apomorphine-induced emesis but doses of dexamethasone up to 20 mg/kg were without effect to modify morphine- or copper sulphate-induced emesis. The combination of dexamethasone 2.5 mg/kg with ondansetron 0.1 mg/kg did not have additive effects to reduce cisplatin-induced emesis but did reduce significantly the total numbers of episodes recorded. Ondansetron 1 mg/kg was without effect to modify apomorphine-, morphine- or copper sulphate-induced emesis but the combination pretreatment of ondansetron 1 mg/kg with dexamethasone 2.5 and 5 mg/kg reduced significantly apomorphine-induced retching. Data are discussed in terms of the antiemetic effectiveness of dexamethasone to antagonize chemotherapy-induced emesis in man.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8684601     DOI: 10.1016/0028-3908(95)00137-9

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  Mechanism of the prostanoid TP receptor agonist U46619 for inducing emesis in the ferret.

Authors:  Kelvin K W Kan; Man P Ngan; Man K Wai; John A Rudd
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-11       Impact factor: 3.000

2.  The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret.

Authors:  J A Rudd; C C Jordan; R J Naylor
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Reduced normogastric electrical activity associated with emesis: a telemetric study in ferrets.

Authors:  Nathalie Percie du Sert; Kit M Chu; Man K Wai; John A Rudd; Paul Lr Andrews
Journal:  World J Gastroenterol       Date:  2009-12-28       Impact factor: 5.742

4.  Cisplatin-induced early and delayed emesis in the pigeon.

Authors:  S Tanihata; H Igarashi; M Suzuki; T Uchiyama
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

5.  Purinergic P2X receptor activation induces emetic responses in ferrets and Suncus murinus (house musk shrews).

Authors:  Y Nagakura; S Kakimoto; N Matsuoka
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

Review 6.  Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting.

Authors:  Charles C Horn; William J Wallisch; Gregg E Homanics; John P Williams
Journal:  Eur J Pharmacol       Date:  2013-10-26       Impact factor: 4.432

7.  An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret.

Authors:  J A Rudd; R J Naylor
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

Review 8.  Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT₃ receptor antagonists.

Authors:  N Percie du Sert; J A Rudd; C C Apfel; P L R Andrews
Journal:  Cancer Chemother Pharmacol       Date:  2010-05-28       Impact factor: 3.333

9.  Glucocorticoid resistance of migration and gene expression in a daughter MDA-MB-231 breast tumour cell line selected for high metastatic potential.

Authors:  Ebony R Fietz; Christine R Keenan; Guillermo López-Campos; Yan Tu; Cameron N Johnstone; Trudi Harris; Alastair G Stewart
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.